Shares of Straumann Holding AG (OTCMKTS:SAUHY – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the eight analysts that are covering the company, MarketBeat Ratings reports. Two analysts have rated the stock with a sell rating, one has issued a hold rating, four have issued a buy rating and one has issued a strong buy rating on the company.
Several equities analysts have recently issued reports on the company. Berenberg Bank raised Straumann to a “strong-buy” rating in a research report on Thursday, September 17th. The Goldman Sachs Group upgraded shares of Straumann from a “neutral” rating to a “buy” rating in a research note on Monday, September 14th. UBS Group raised shares of Straumann from a “neutral” rating to a “buy” rating in a research report on Tuesday, September 1st. Citigroup restated a “sell” rating on shares of Straumann in a research note on Wednesday, October 21st. Finally, Deutsche Bank cut shares of Straumann from a “buy” rating to a “hold” rating in a report on Friday, August 21st.
Get Our Latest Research Report on SAUHY
Straumann Trading Down 0.0%
About Straumann
Straumann Group is a Swiss dental technology company that develops and supplies products and services for tooth replacement and oral tissue regeneration. Its offerings include dental implant systems, prosthetic components, biomaterials and related solutions used by dental professionals and laboratories. The company also provides digital dentistry technologies and services, including tools for treatment planning and dental restoration, as well as orthodontic products such as clear aligners through its ClearCorrect brand.
Recommended Stories
- Five stocks we like better than Straumann
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for Straumann Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Straumann and related companies with MarketBeat.com's FREE daily email newsletter.
